22O Association of Biomarkers with Response to Coformulated Vibostolimab/pembrolizumab (vibo/pembro) in Metastatic Cervical Cancer (CC): Exploratory Analysis from the Phase II KEYVIBE-005 Study
ESMO Open(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined